Merck, as it prepares a new version of its cancer blockbuster Keytruda, gets a boost in its patent dispute with Halozyme ...

The biodefense market is projected to grow from USD 0.89 billion in 2025 to USD 1.81 billion by 2030 at a CAGR of 15.1% during the forecast period according to a new report by MarketsandMarketstm. The ...

The use of 3D printers to create living tissues and organs is revolutionizing medicine—but University of Queensland research ...

Texas has solidified its reputation as the epicenter of patent litigation in the United States, with the Eastern District ...

MoonLake's shares rose 19% in extended trading. Merck submitted a nonbinding offer for MoonLake earlier this year, according ...

P&G saw three new federal suits that center on allegedly deceptive environmental claims on its Charmin and Puffs paper ...

The company’s recent acquisition of International Patent No. 7635292, alongside U.S. Patent No ... helping investors make more informed decisions about emerging opportunities in the biotech sector. In ...

13. The now 13-year-long legal saga over who invented CRISPR took yet another unexpected turn on Monday, in a ruling that could not only change U.S. ownership of patent rights to the ...